Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

Macrophage dysfunction and susceptibility to pulmonary Pseudomonas aeruginosa infection in surfactant protein C-deficient mice.

Glasser SW, Senft AP, Whitsett JA, Maxfield MD, Ross GF, Richardson TR, Prows DR, Xu Y, Korfhagen TR.

J Immunol. 2008 Jul 1;181(1):621-8.

2.

Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection.

LeVine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR.

Am J Respir Cell Mol Biol. 1998 Oct;19(4):700-8.

PMID:
9761768
3.

Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa.

Giannoni E, Sawa T, Allen L, Wiener-Kronish J, Hawgood S.

Am J Respir Cell Mol Biol. 2006 Jun;34(6):704-10. Epub 2006 Feb 2.

4.

Surfactant protein C-deficient mice are susceptible to respiratory syncytial virus infection.

Glasser SW, Witt TL, Senft AP, Baatz JE, Folger D, Maxfield MD, Akinbi HT, Newton DA, Prows DR, Korfhagen TR.

Am J Physiol Lung Cell Mol Physiol. 2009 Jul;297(1):L64-72. doi: 10.1152/ajplung.90640.2008. Epub 2009 Mar 20.

5.

Human amnion epithelial cells do not abrogate pulmonary fibrosis in mice with impaired macrophage function.

Murphy SV, Shiyun SC, Tan JL, Chan S, Jenkin G, Wallace EM, Lim R.

Cell Transplant. 2012;21(7):1477-92.

PMID:
22507554
6.

Genetic replacement of surfactant protein-C reduces respiratory syncytial virus induced lung injury.

Glasser SW, Senft AP, Maxfield MD, Ruetschilling TL, Baatz JE, Page K, Korfhagen TR.

Respir Res. 2013 Feb 12;14:19. doi: 10.1186/1465-9921-14-19.

7.

Type IV pilus glycosylation mediates resistance of Pseudomonas aeruginosa to opsonic activities of the pulmonary surfactant protein A.

Tan RM, Kuang Z, Hao Y, Lee F, Lee T, Lee RJ, Lau GW.

Infect Immun. 2015 Apr;83(4):1339-46. doi: 10.1128/IAI.02874-14. Epub 2015 Jan 20.

9.

Increased and prolonged pulmonary fibrosis in surfactant protein C-deficient mice following intratracheal bleomycin.

Lawson WE, Polosukhin VV, Stathopoulos GT, Zoia O, Han W, Lane KB, Li B, Donnelly EF, Holburn GE, Lewis KG, Collins RD, Hull WM, Glasser SW, Whitsett JA, Blackwell TS.

Am J Pathol. 2005 Nov;167(5):1267-77.

10.

Pseudomonas aeruginosa elastase provides an escape from phagocytosis by degrading the pulmonary surfactant protein-A.

Kuang Z, Hao Y, Walling BE, Jeffries JL, Ohman DE, Lau GW.

PLoS One. 2011;6(11):e27091. doi: 10.1371/journal.pone.0027091. Epub 2011 Nov 1.

11.

IFN regulatory factor 3 contributes to the host response during Pseudomonas aeruginosa lung infection in mice.

Carrigan SO, Junkins R, Yang YJ, Macneil A, Richardson C, Johnston B, Lin TJ.

J Immunol. 2010 Sep 15;185(6):3602-9. doi: 10.4049/jimmunol.0903429. Epub 2010 Aug 18.

12.

Modulation of macrophage function for defence of the lung against Pseudomonas aeruginosa.

Speert DP, Wong SY, Macdonald M, Sargeant R.

Behring Inst Mitt. 1997 Feb;(98):274-82. Review.

PMID:
9382751
13.

Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Ballinger MN, Paine R 3rd, Serezani CH, Aronoff DM, Choi ES, Standiford TJ, Toews GB, Moore BB.

Am J Respir Cell Mol Biol. 2006 Jun;34(6):766-74. Epub 2006 Feb 10.

14.

Persistence of LPS-induced lung inflammation in surfactant protein-C-deficient mice.

Glasser SW, Maxfield MD, Ruetschilling TL, Akinbi HT, Baatz JE, Kitzmiller JA, Page K, Xu Y, Bao EL, Korfhagen TR.

Am J Respir Cell Mol Biol. 2013 Nov;49(5):845-54. doi: 10.1165/rcmb.2012-0374OC.

15.

The flagellum of Pseudomonas aeruginosa is required for resistance to clearance by surfactant protein A.

Zhang S, McCormack FX, Levesque RC, O'Toole GA, Lau GW.

PLoS One. 2007 Jun 27;2(6):e564.

16.

Role of cystic fibrosis transmembrane conductance regulator in pulmonary clearance of Pseudomonas aeruginosa in vivo.

Chroneos ZC, Wert SE, Livingston JL, Hassett DJ, Whitsett JA.

J Immunol. 2000 Oct 1;165(7):3941-50.

17.

Mutation of SFTPC in infantile pulmonary alveolar proteinosis with or without fibrosing lung disease.

Tredano M, Griese M, Brasch F, Schumacher S, de Blic J, Marque S, Houdayer C, Elion J, Couderc R, Bahuau M.

Am J Med Genet A. 2004 Apr 1;126A(1):18-26.

PMID:
15039969
18.

Defective phagocytosis and clearance of Pseudomonas aeruginosa in the lung following bone marrow transplantation.

Ojielo CI, Cooke K, Mancuso P, Standiford TJ, Olkiewicz KM, Clouthier S, Corrion L, Ballinger MN, Toews GB, Paine R 3rd, Moore BB.

J Immunol. 2003 Oct 15;171(8):4416-24.

19.

IL-27 controls sepsis-induced impairment of lung antibacterial host defence.

Cao J, Xu F, Lin S, Song Z, Zhang L, Luo P, Xu H, Li D, Zheng K, Ren G, Yin Y.

Thorax. 2014 Oct;69(10):926-37. doi: 10.1136/thoraxjnl-2014-205777. Epub 2014 Jul 29. Erratum in: Thorax. 2015 Mar;70(3):243.

PMID:
25074706
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk